Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-1294]
 AGENCY: Drug Enforcement Administration, Justice.
 ACTION: Notice of application.
 SUMMARY: VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to 
                        **SUPPLEMENTARY INFORMATION**
                         listed below for further drug information.
 DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before December 26, 2023. Such persons may also file a written request for a hearing on the application on or before December 26, 2023.
 ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to 
                        *https://www.regulations.gov*
                         and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on 
                        *https://www.regulations.gov.*
                         If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on November 6, 2023, VHG Labs DBA LGC Standards, 3 Perimeter Road, Manchester, New Hampshire 03103-3341, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Controlled substance
Drug code
ScheduleAmineptine (7-[(10,11-dihydro-5Hdibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)
1219
IMesocarb (N-phenyl-N′-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate)
1227
I3-Fluoro-N-methylcathinone (3-FMC)
1233
I4-Fluoro-N-methylcathinone (4-FMC) 1238 I N
1238
IPentedrone (α-methylaminovalerophenone)
1246
I4-Methyl-N-ethylcathinone (4-MEC)
1249
IMethiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine) 1478 I N
1478
IN,N-Dimethylamphetamine
1480
IFenethylline
1503
I4-Methylaminorex (cis isomer)
1590
I4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-1595 I N methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)
1595
IMecloqualone
2572
IADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)
7010
I5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
7011
IAB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)
7012
IJWH-019 (1-Hexyl-3-(1-naphthoyl)indole)
7019
IFUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate)
7021
IAB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)
7023
ITHJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone)
7024
I5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide)
7025
IAB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)
7031
I5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)
7034
I5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate)
7041
IMDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate)
7042
I5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide)
7049
I( print page 82402)4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide)
7089
IJWH-073 (1-Butyl-3-(1-naphthoyl)indole)
7173
IJWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole)
7200
IAM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole)
7201
IPB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate)
7222
I5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate)
7225
IN-ethylhexedrone 7246 I N
7246
IAlpha-ethyltryptamine
7249
I2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine)
7286
ICP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol)
7297
I2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine
7348
I2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine)
7385
I3,4,5-Trimethoxyamphetamine
7390
I4-Bromo-2,5-dimethoxyamphetamine
7391
I4-Bromo-2,5-dimethoxyphenethylamine
7392
I4-Methyl-2,5-dimethoxyamphetamine
7395
I2,5-Dimethoxy-4-ethylamphetamine
7399
I3,4-Methylenedioxyamphetamine
7400
I3,4-Methylenedioxy-N-ethylamphetamine
7404
IAlpha-methyltryptamine
7432
IDiethyltryptamine
7434
IDimethyltryptamine
7435
I5-Methoxy-N,N-diisopropyltryptamine
7439
IN-Ethyl-1-phenylcyclohexylamine
7455
I1-(1-Phenylcyclohexyl)pyrrolidine
7458
I1-[1-(2-Thienyl)cyclohexyl]piperidine
7470
IN-Benzylpiperazine
7493
I2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine)
7508
I2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine)
7509
I2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine)
7518
I2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine)
7519
I2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine)
7521
I2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine)
7524
I2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine)
7532
I25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine)
7536
I25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine)
7537
I25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine)
7538
IN-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one)
7543
Ialpha-pyrrolidinopentiophenone (α-PVP)
7545
Ialpha-pyrrolidinobutiophenone (α-PBP)
7546
IEthylone
7547
IAM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole)
7694
IDifenoxin
9168
INicomorphine
9312
IDrotebanol
9335
IU-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide)
9547
IAH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide))
9551
IMT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine))
9560
IAcetylmethadol
9601
IAlphameprodine
9604
IBenzethidine
9606
IBetameprodine
9608
IClonitazene
9612
IDextromoramide
9613
IIsotonotazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)
9614
IDimenoxadol
9617
IDimepheptanol
9618
IDimethylthiambutene
9619
IDioxaphetyl butyrate
9621
IDipipanone
9622
IEtonitazene
9624
IKetobemidone
9628
ILevomoramide
9629
INoracymethadol
9633
INormethadone
9635
IPiritramide
9642
IRacemoramide
9645
I1-Methyl-4-phenyl-4-propionoxypiperidine
9661
IMetonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)ethan-1-amine
9757
IProtonitazene (N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine)
9759
IPara-Fluorofentanyl
9812
I3-Methylfentanyl
9813
I4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)
9824
I( print page 82403)Beta-hydroxyfentanyl
9830
IBeta-hydroxy-3-methylfentanyl
9831
I3-Methylthiofentanyl
9833
IFuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide)
9834
IThiofentanyl
9835
IBeta-hydroxythiofentanyl
9836
IOcfentanil
9838
Ibeta′-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as β′-phenyl fentanyl; 3-phenylpropanoyl fentanyl)
9842
IN-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide
9843
ICrotonyl fentanyl ((E-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide)
9844
ICyclopropyl Fentanyl
9845
Iortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl fentanyl)
9846
INabilone
7379
IIAlphaprodine
9010
IILevomethorphan
9210
IIRacemethorphan
9732
IIAlfentanil
9737
II
 The company plans to import the listed controlled substances for distribution for analytical testing purposes. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale. Claude Redd, Acting Deputy Assistant Administrator.


[FR Doc. 2023-25989 Filed 11-22-23; 8:45 am] BILLING CODE P